News | October 08, 2012

Cook Medical Launches Zilver Vena Venous Self-Expanding Stent in Canada

Zilver Vena is Canada’s only venous stent indicated for use in the iliofemoral veins

Cook Medical Zilver Vena Venous Self-Expanding Stent

October 8, 2012 — Following Health Canada approval, Cook Medical made the Zilver Vena Venous Self-Expanding Stent available to physicians across Canada at the 2012 Annual Meeting of the Canadian Society for Vascular Surgery. Designed to restore blood flow in obstructed iliofemoral veins, Zilver Vena provides physicians with a tool designed specifically for stenting obstructed iliofemoral veins. This condition can arise for various reasons, including post-thrombotic syndrome in deep vein thrombosis (DVT) patients.

According to a study by Dr. A. Rosales of the department of vascular surgery at Oslo University Hospital in Norway, post-thrombotic syndrome (PTS) characterized by reflux and/or obstruction can be expected to develop in up to 40 percent of DVT patients.[1]

Built on Cook’s established line of Zilver stents, the Zilver Vena stent is a flexible, self-expanding stent made with “shape memory” nitinol. Zilver Vena was developed to address a challenging clinical issue, the need to establish and maintain blood flow in obstructed iliofemoral veins.

The stent provides flexibility, consistent radial force and continuous stent-to-vein wall apposition from end to end. Zilver Vena is currently available in 14 and 16 mm diameters and 60, 100 and 140 mm lengths to enable precise placement, and is compatible with 7 French sheaths and 9 French guiding catheters.

“As the only device of its kind available in Canada, Zilver Vena gives physicians a new treatment option for stenting diseased veins,” said Rob Lyles, vice president and global leader of Cook Medical’s Peripheral Intervention clinical division.

The Zilver Vena stent is currently under regulatory review by the U.S. Food and Drug Administration (FDA) and is not approved for sale in the United States.

For more information: www.cookmedical.com

Reference:

1. Rosales A. Sandbaek G, Jørgensen JJ. "Stenting for chronic post-thrombotic vena cava and iliofemoral venous occlusions: mid-term patency and clinical outcome." Eur J Vasc Endovasc Surg. 2010;40(2):234-240.


Related Content

News | Stents

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...

Home October 16, 2024
Home
News | Stents

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
News | Stents

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
News | Stents

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

Home April 17, 2024
Home
News | Stents

March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact ...

Home March 08, 2024
Home
News | Stents

January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...

Home January 19, 2024
Home
News | Stents

November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home November 29, 2023
Home
News | Stents

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
News | Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...

Home June 13, 2023
Home
News | Stents

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

Home March 05, 2023
Home
Subscribe Now